The uptake of extracellular lipids via CD36 and the lipolysis-stimulated lipoprotein receptor (LSR) is often upregulated in tumors and is also responsive to PI3K/mTOR signaling, reinforcing the lipid supply for cancer progression (23–25). This evidence concerns the gene CD36 and cancer.